How will Brexit affect travel for people with long-term health conditions? Lords to hear evidence
The House of Lords EU Home Affairs Sub-Committee will continue taking evidence for its inquiry into Brexit: reciprocal healthcare on Wednesday 1 November. The Committee will question Kidney Care UK and Diabetes UK.
The Committee will consider whether travel insurance will increase and how access to treatment might be affected for those living with diabetes and kidney conditions both in the UK and in the EU after Brexit.
At 10:30am the Committee will hear from:
- Fiona Loud, Policy Director, Kidney Care UK
- Robin Hewings, Head of Policy, Knowledge and Insight, Diabetes UK
Questions the witnesses are likely to be asked include:
- Will people with kidney conditions or diabetes have to pay higher travel insurance premiums should the UK and EU not come to a deal on reciprocal healthcare?
- What reciprocal healthcare priorities would stakeholders hope to see reflected in a potential Withdrawal Agreement, and what sort of transitional arrangements would they wish to see?
- How might non-resident EU-27 citizens who visit the UK access healthcare for long-term conditions post-Brexit?
The evidence session will begin at 10.30am in Committee Room 2 of the House of Lords.
